About
Dongxing Zha is founder and CEO of Keyway TCR Discovery and co-founder and CEO of Ypsilon Therapeutics, companies focused on TCR-based and TCRm therapeutics for cancer. He has over two decades of experience in immuno-oncology and biologics research and development, with prior scientific leadership roles at MD Anderson Cancer Center and Merck Research Laboratories, where he led discovery programs in bispecifics, TCRs, and cell therapy.
Experience
- Ypsilon TherapeuticsDirector Board of Directorscurrent2022 — present
- Ypsilon TherapeuticsFounder and CEOcurrent2022 — presentHouston, Texas
- Alloy Therapeutics, Inc.CTO, TCR Discovery and Engineering at Alloy Therapeutics | Founder and CEO at Keyway TCR Discovery2021 — 2025Boston, Massachusetts, United States
- MD Anderson Cancer CenterInstitute Head, ORBIT Platform2019 — 2021Greater Houston
- MD Anderson Cancer CenterInstitute Associate Director2017 — 2019Greater Houston
- MD Anderson Cancer CenterInstitute Group Leader2014 — 2017Greater Houston
- MerckResearch Fellow and Group Leader2006 — 2014
- GlycoFiSenior Research Scientist2002 — 2006Lebanon, NH
- Max-Planck-Institut für KohlenforschungPostdoctoral Fellow1999 — 2002
- Novo NordiskResearch Scientist1998 — 1999
- Chinese Academy of SciencesScientist1997 — 1998
Education
- Huazhong Agricultural UniversityDoctor of Philosophy - PhD, Microbiology, General
Skills & more
Oncology3Pharmaceutics2Drug Discovery32Monoclonal Antibodies18Antibodies34Protein Engineering11yeast surface displayDirected evolutionPreclinical studies1Autoimmune DiseasesSystemic lupus erythematosusPhage display
+12 more
Bispecific antibodiesStandard Molecular BiologyB-cell biologyImmunomodulatoryGlycobiologyProtein expression and yield improvementError-prone PCRDNA library constructionBiomarkersDrug DevelopmentAssay DevelopmentBiochemistryFrom Dongxing's professional profile.
Colleagues at 82VS
Andrei Ramirez-Valdez
Venture Associate at 82VS
Andrew Peterson
Founder / EIR at 82VS
Arthur Suckow
Investor at 82VS
Caitlin Tolman
Chief Operating Officer at 82VS
Carlos Loya
Venture Partner & Founder at 82VS
Colby Jordan
Vice President, Capital Formation at 82VS
Errik Anderson
Board Director at Basecamp Fund
Hemanta Baruah
Founder / EIR at 82VS
Frequently asked questions
- Where does Dongxing Zha work?
- Dongxing Zha is Founder / EIR at 82VS.
Shared employers
Also worked at Ypsilon Therapeutics2
Also worked at Alloy Therapeutics, Inc.20
Jesse RobbinsFounder and Investor in AI Developer ToolsChaya PatelPrincipal at Mission BiocapitalErrik AndersonBoard Director at Basecamp FundAlasdair ThongFounding Partner at Selvedge VentureEsra BerkolChief of Staff at Selvedge VentureMike SchmidtGeneral Partner, President and Head of 82VS Boston at 82VS
+ 14 more
Also worked at MD Anderson Cancer Center15
Evan PunPortfolio Support at 8VCKevin CyrResearch Associate at Global BioAccess FundAleece HobsonVenture Partner at HX Venture FundAnil ShettyLife Science Committee Chair at Houston Angel NetworkSusan BrennanExecutive in Residence at EnerTech CapitalMarianna FeretzakiSenior Associate at BioMedPartners
+ 9 more
Also worked at Merck103
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesAndrea van ElsasInvestor at Third Rock Ventures
+ 97 more